Bellevue Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.5K | Hold |
|
|||||
|
2025
Q1 | $55K | Sell |
|
|||||
|
2024
Q4 | $406K | Buy |
|
|||||
|
2024
Q3 | $511K | Sell |
|
|||||
|
2024
Q2 | $1.37M | Sell |
|
|||||
|
2024
Q1 | $1.3M | Sell |
|
|||||
|
2023
Q4 | $2.2M | Sell |
|
|||||
|
2023
Q3 | $4.45M | Sell |
|
|||||
|
2023
Q2 | $7.29M | Buy |
|
|||||
|
2023
Q1 | $6.87M | Sell |
|
|||||
|
2022
Q4 | $7.87M | Sell |
|
|||||
|
2022
Q3 | $7.67M | Buy |
|
|||||
|
2022
Q2 | $4.46M | Sell |
|
|||||
|
2022
Q1 | $4.71M | Sell |
|
|||||
|
2021
Q4 | $126M | Sell |
|
|||||
|
2021
Q3 | $149M | Sell |
|
|||||
|
2021
Q2 | $183M | Sell |
|
|||||
|
2021
Q1 | $156M | Sell |
|
|||||
|
2020
Q4 | $138M | Buy |
|
|||||
|
2020
Q3 | $2.44M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.69M | Buy |
|
|||||
|
2019
Q4 | $148K | Sell |
|
|||||
|
2019
Q3 | $7.53M | Buy |
|
|||||
|
2019
Q2 | $6.91M | Buy |
|
|||||
|
2019
Q1 | $2M | Sell |
|
|||||
|
2018
Q4 | $7.6M | Sell |
|
|||||
|
2018
Q3 | $13.9M | Sell |
|
|||||
|
2018
Q2 | $11.4M | Sell |
|
|||||
|
2018
Q1 | $12.7M | Sell |
|
|||||
|
2017
Q4 | $16.7M | Sell |
|
|||||
|
2017
Q3 | $18.4M | Sell |
|
|||||
|
2017
Q2 | $16.7M | Buy |
|
|||||
|
2017
Q1 | $14.6M | Buy |
|
|||||
|
2016
Q4 | $13.9M | Sell |
|
|||||
|
2016
Q3 | $17.1M | Hold |
|
|||||
|
2016
Q2 | $13.2M | Sell |
|
|||||
|
2016
Q1 | $19.9M | Buy |
|